BACKGROUND: African American men (AAM) are under-represented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but needs validation in AAM. Engaging AAM as citizen scientists (CSs) may improve participation of AAM in PCa research.Results and Lessons Learned: Eight CSs completed all training modules and 139 AAM were recruited. Challenges included equity in research leadership among multiple principal investigators (PIs) and coordinating CSs trainings. CONCLUSIONS: Engaging AAM CSs can support engaging/recruiting AAM in PCa biomarker validation research. Equity among multiple stakeholders can be challenging, but proves beneficial in engaging AAM in research. OBJECTIVES: Assess feasibility of mobilizing CSs to recruit AAM as controls for PHI PCa validation biomarker study. METHODS: We highlight social networks/assets of stakeholders, CSs curriculum development/implementation, and recruitment of healthy controls for PHI validation.
BACKGROUND: African American men (AAM) are under-represented in prostate cancer (PCa) research despite known disparities. Screening with prostate-specific antigen (PSA) has low specificity for high-grade PCa leading to PCa over diagnosis. The Prostate Health Index (PHI) has higher specificity for lethal PCa but needs validation in AAM. Engaging AAM as citizen scientists (CSs) may improve participation of AAM in PCa research.Results and Lessons Learned: Eight CSs completed all training modules and 139 AAM were recruited. Challenges included equity in research leadership among multiple principal investigators (PIs) and coordinating CSs trainings. CONCLUSIONS: Engaging AAM CSs can support engaging/recruiting AAM in PCa biomarker validation research. Equity among multiple stakeholders can be challenging, but proves beneficial in engaging AAM in research. OBJECTIVES: Assess feasibility of mobilizing CSs to recruit AAM as controls for PHI PCa validation biomarker study. METHODS: We highlight social networks/assets of stakeholders, CSs curriculum development/implementation, and recruitment of healthy controls for PHI validation.
Authors: Yuanyuan Liang; Donna P Ankerst; Ziding Feng; Rong Fu; Janet L Stanford; Ian M Thompson Journal: Urol Oncol Date: 2012-05-01 Impact factor: 3.498
Authors: Donna P Ankerst; Andreas Boeck; Stephen J Freedland; J Stephen Jones; Angel M Cronin; Monique J Roobol; Jonas Hugosson; Michael W Kattan; Eric A Klein; Freddie Hamdy; David Neal; Jenny Donovan; Dipen J Parekh; Helmut Klocker; Wolfgang Horninger; Amine Benchikh; Gilles Salama; Arnauld Villers; Daniel M Moreira; Fritz H Schröder; Hans Lilja; Andrew J Vickers; Ian M Thompson Journal: World J Urol Date: 2012-04-22 Impact factor: 4.226
Authors: M Tsivian; L L Bañez; C J Keto; M R Abern; P Qi; L Gerber; J W Moul; T J Polascik Journal: Prostate Cancer Prostatic Dis Date: 2012-10-02 Impact factor: 5.554
Authors: Alicia K Matthews; Marcus Murray; Josef Ben Levi; David Odell; Rohan Jeremiah; LeAndre Moore; Damilola Oyaluade; Alexis Chappel; Larisa Burke; Karriem Watson Journal: Am J Mens Health Date: 2022 May-Jun
Authors: Karriem S Watson; Leilah D Siegel; Vida A Henderson; Marcus Murray; I Beverly Chukwudozie; David Odell; James Stinson; Ose Ituah; Josef Ben Levi; Marian L Fitzgibbon; Sage Kim; Phoenix Matthews Journal: Am J Mens Health Date: 2020 Sep-Oct